Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.81B
Enterprise Value6.92B
P/E Ratio-2,427.63
PEG Ratio23.83
Price/Sales Ratio6.15
Price/Book Ratio4.95
Enterprise/Revenue6.39
Enterprise/EBITDA6,210.4

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0
Operating Margin-0.03
AD

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue1.22B
Revenue/Share9.22
Gross Profit634.32M
EBITDA277.26M
Net Income203.87M
Diluted EPS1.86

Balance Sheet

Total Cash533M
Total Cash/Share4.88
Total Debt712.72M
Total Debt/Equity0.58
Current Ratio1.67
Book Value Per Share11.3

Price History

52-Week Change-5.84
52-Week High80.7
52-Week Low46.68
Moving Average 50 Days65.17
Moving Average 200 Days61.39

Statistics

Average Volume2.78M
Shares Outstanding112M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.19
Trailing Annual Dividend Yield0.34
Payout Ratio-26.58
Last Split Factor7:5
Last Split DateMay 12, 2023
AD